<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01749371</url>
  </required_header>
  <id_info>
    <org_study_id>12-189</org_study_id>
    <nct_id>NCT01749371</nct_id>
  </id_info>
  <brief_title>Vitamin E Supplementation in Burned Patients</brief_title>
  <official_title>Vitamin E Supplementation in Burned Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shriners Hospitals for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Memorial Hermann Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E
      short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn
      injury and, in the process, decrease the secondary consequences of burn injury, including
      lung injury and impaired wound healing. This may improve the quality of life of the burn
      patient by preventing pathophysiology that may result from oxidative stress and may reduce
      hospital stay. Our research will lay the foundation for the future development of effective,
      safe, and economic therapeutic interventions to treat burn injury-associated metabolic
      abnormalities. Also, it will provide the basis for the development of supplemental
      regulations and pharmacotherapy to treat burn patients with vitamin E. The risks are very
      reasonable in relation to the anticipated benefits to our subjects because a) vitamin E is a
      simple vitamin that is abundant and approved for clinical use, and b) the subjects will be
      monitored consistently for the minimal increased tendency to bleed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please see above.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2013</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Alpha- and Gamma-Tocopherol</measure>
    <time_frame>Days 0-30</time_frame>
    <description>Plasma measurements of alpha- and gamma-tocopherol as an indicator of antioxidant status</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary Function Testing</measure>
    <time_frame>Day 30</time_frame>
    <description>Assessment of pulmonary function by measuring variables such as functional vital capacity of the lungs and volume ventilation in an effort-dependent exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Stress Test</measure>
    <time_frame>Day 30</time_frame>
    <description>Assessment of strength and cardiopulmonary function through use of exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Healing</measure>
    <time_frame>Days 0-30</time_frame>
    <description>Assessment of variables of the wound such as redness and scar height</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma and Urine Malondialdehyde, Isoprostanes, Vitamin E Metabolites</measure>
    <time_frame>Days 0-30</time_frame>
    <description>Assessment of antioxidant and oxidant status in plasma (short-term)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adipose Alpha- and Gamma-Tocopherol</measure>
    <time_frame>Days 0-30</time_frame>
    <description>Assessment of antioxidant and oxidant status in adipose (long-term)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Burn</condition>
  <arm_group>
    <arm_group_label>Early Vitamin E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin E is administered from Days 1-15 after the initial excision surgery after admission.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed Vitamin E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin E is administered from Days 16-30 after the initial excision surgery after admission.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>1200 IU dl-alpha tocopheryl acetate after the initial excision surgery after admission (days 1-15 or days 16-30)</description>
    <arm_group_label>Early Vitamin E</arm_group_label>
    <arm_group_label>Delayed Vitamin E</arm_group_label>
    <other_name>dl-Alpha Tocopheryl</other_name>
    <other_name>Alpha Tocopherol</other_name>
    <other_name>Aqueous Vitamin E Oral Drops</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 16 - 85 years

          -  â‰¥40% total body surface area burn

        Exclusion Criteria:

          -  Septic shock

          -  Bleeding disorders

          -  Diabetes, or on diabetes medications or anti-lipidemic agents

          -  Arthritis

          -  Known kidney/renal disease, endocrine disease, cancer, heart disease, osteoporosis,
             liver disease

          -  Congestive heart failure

          -  Positive hepatitis or HIV screens

          -  Pregnancy (women)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Perenlei Enkhbaatar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Linda E Sousse, PhD, MBA</last_name>
    <role>Study Director</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center, Parkland Health and Hospital System</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch: Blocker Burn Unit and Shriners Hospitals for Children</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Hospital Burn Intensive Care Unit</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2012</study_first_submitted>
  <study_first_submitted_qc>December 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2012</study_first_posted>
  <last_update_submitted>February 20, 2018</last_update_submitted>
  <last_update_submitted_qc>February 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alpha-Tocopherol</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Oxidative Stress</keyword>
  <keyword>Malondialdehyde</keyword>
  <keyword>Isoprostanes</keyword>
  <keyword>Lung Dysfunction</keyword>
  <keyword>Wound Healing</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

